Close

PTC Therapeutics (PTCT) Gains as Sarepta's Eteplirsen Approved

Go back to PTC Therapeutics (PTCT) Gains as Sarepta's Eteplirsen Approved
PTC THERAPEUTICS (NASDAQ: PTCT) Delayed: 29.09 -0.35 (1.19%)
Previous Close $29.44    52 Week High $35.40 
Open $29.48    52 Week Low $4.03 
Day High $29.83    P/E 3.09 
Day Low $29.00    EPS $9.40 
Volume 1,083,977